-
1
-
-
84949470041
-
Immune tolerance: high-dose regimen
-
Rodriguez-Merchan E., and Lee C. (Eds), Blackwell Science, Ltd., Oxford, England
-
Brackmann H., and Wallny T. Immune tolerance: high-dose regimen. In: Rodriguez-Merchan E., and Lee C. (Eds). Inhibitors in Patients With Hemophilia (2002), Blackwell Science, Ltd., Oxford, England 45-48
-
(2002)
Inhibitors in Patients With Hemophilia
, pp. 45-48
-
-
Brackmann, H.1
Wallny, T.2
-
2
-
-
0031856491
-
Factor VIII inhibitors in mild and moderateseverity haemophilia A
-
Hay C. Factor VIII inhibitors in mild and moderateseverity haemophilia A. Haemophilia 4 4 (1998) 558-563
-
(1998)
Haemophilia
, vol.4
, Issue.4
, pp. 558-563
-
-
Hay, C.1
-
3
-
-
43449099634
-
-
Kasper CK. Diagnosis and Management of Inhibitors to Factors VIII and IX. An Introductory Discussion for Physicians. Vol No. 34. Montréal, Québec: World Federation of Hemophilia; 2004.
-
Kasper CK. Diagnosis and Management of Inhibitors to Factors VIII and IX. An Introductory Discussion for Physicians. Vol No. 34. Montréal, Québec: World Federation of Hemophilia; 2004.
-
-
-
-
4
-
-
4644334185
-
Prevention of bleeds in hemophilia patients with inhibitors: emerging data and clinical direction
-
Leissinger C. Prevention of bleeds in hemophilia patients with inhibitors: emerging data and clinical direction. Am J Hematol 77 2 (2004) 187-193
-
(2004)
Am J Hematol
, vol.77
, Issue.2
, pp. 187-193
-
-
Leissinger, C.1
-
5
-
-
0034107545
-
Human coagulation factor FVIIa (recombinant) in the management of limbthreatening bleeds unresponsive to alternative therapies: results from the NovoSeven emergency-use rogramme in patients with severe haemophilia or with acquired inhibitors
-
Arkin S., Blei F., Fetten J., and et a. Human coagulation factor FVIIa (recombinant) in the management of limbthreatening bleeds unresponsive to alternative therapies: results from the NovoSeven emergency-use rogramme in patients with severe haemophilia or with acquired inhibitors. Blood Coagul Fibrinolysis 11 3 (2000) 255-259
-
(2000)
Blood Coagul Fibrinolysis
, vol.11
, Issue.3
, pp. 255-259
-
-
Arkin, S.1
Blei, F.2
Fetten, J.3
et, a.4
-
6
-
-
33846185403
-
A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study
-
Astermark J., Donfield S., DiMichele D., and et a. A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. Blood 109 2 (2007) 546-551
-
(2007)
Blood
, vol.109
, Issue.2
, pp. 546-551
-
-
Astermark, J.1
Donfield, S.2
DiMichele, D.3
et, a.4
-
7
-
-
0025180213
-
Efficacy and safety of vapor-heated anti-inhibitor coagulant complex in hemophilia patients. FEIBA Study Group
-
Hilgartner M., Aledort L., Andes A., and Gill J. Efficacy and safety of vapor-heated anti-inhibitor coagulant complex in hemophilia patients. FEIBA Study Group. Transfusion 30 7 (1990) 626-630
-
(1990)
Transfusion
, vol.30
, Issue.7
, pp. 626-630
-
-
Hilgartner, M.1
Aledort, L.2
Andes, A.3
Gill, J.4
-
8
-
-
17144437423
-
Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors
-
Key N., Aledort L., Beardsley D., and et a. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors. Thromb Haemost 80 6 (1998) 912-918
-
(1998)
Thromb Haemost
, vol.80
, Issue.6
, pp. 912-918
-
-
Key, N.1
Aledort, L.2
Beardsley, D.3
et, a.4
-
9
-
-
0030837755
-
Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors
-
Negrier C., Goudemand J., Sultan Y., Bertrand M., Rothschild C., Lauroua P., and French FEIBA Study Group. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. Thromb Haemost 77 6 (1997) 1113-1119
-
(1997)
Thromb Haemost
, vol.77
, Issue.6
, pp. 1113-1119
-
-
Negrier, C.1
Goudemand, J.2
Sultan, Y.3
Bertrand, M.4
Rothschild, C.5
Lauroua, P.6
French FEIBA Study Group7
-
10
-
-
0031743504
-
Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery
-
Shapiro A., Gilchrist G., Hoots W., Cooper H., and Gastineau D. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost 80 5 (1998) 773-778
-
(1998)
Thromb Haemost
, vol.80
, Issue.5
, pp. 773-778
-
-
Shapiro, A.1
Gilchrist, G.2
Hoots, W.3
Cooper, H.4
Gastineau, D.5
-
11
-
-
11044234837
-
Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX: the updated Norwegian experience
-
Tjønnfjord G. Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX: the updated Norwegian experience. Haemophilia 10 suppl 2 (2004) 41-45
-
(2004)
Haemophilia
, vol.10
, Issue.SUPPL. 2
, pp. 41-45
-
-
Tjønnfjord, G.1
-
12
-
-
0033778140
-
Immune tolerance therapy for haemophilia
-
Ho A., Height S., and Smith M. Immune tolerance therapy for haemophilia. Drugs 60 3 (2000) 547-554
-
(2000)
Drugs
, vol.60
, Issue.3
, pp. 547-554
-
-
Ho, A.1
Height, S.2
Smith, M.3
-
13
-
-
11044235586
-
Inhibitorsin haemophilia: clinical aspects
-
DiMichele D., Rivard G., Hay C., and Antunes S. Inhibitorsin haemophilia: clinical aspects. Haemophilia 10 suppl 4 (2004) 140-145
-
(2004)
Haemophilia
, vol.10
, Issue.SUPPL. 4
, pp. 140-145
-
-
DiMichele, D.1
Rivard, G.2
Hay, C.3
Antunes, S.4
-
14
-
-
34248594449
-
A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high-titre inhibitors
-
Teitel J., Berntorp E., Collins P., and et a. A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high-titre inhibitors. Haemophilia 13 (2007) 256-263
-
(2007)
Haemophilia
, vol.13
, pp. 256-263
-
-
Teitel, J.1
Berntorp, E.2
Collins, P.3
et, a.4
-
15
-
-
20144389671
-
Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry
-
Parameswaran R., Shapiro A., Gill J., and Kessler C. Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry. Haemophilia 11 2 (2005) 100-106
-
(2005)
Haemophilia
, vol.11
, Issue.2
, pp. 100-106
-
-
Parameswaran, R.1
Shapiro, A.2
Gill, J.3
Kessler, C.4
-
16
-
-
43449095901
-
-
Gomperts ED, Astermark J, Gringeri A, Teitel JM. From theory to practice: applying current critical knowledge and treatment strategies to the care of inhibitor patients. Presented at: XXIst Congress of the International Society on Thrombosis and Haemostasis; July 11, 2007; Geneva, Switzerland.
-
Gomperts ED, Astermark J, Gringeri A, Teitel JM. From theory to practice: applying current critical knowledge and treatment strategies to the care of inhibitor patients. Presented at: XXIst Congress of the International Society on Thrombosis and Haemostasis; July 11, 2007; Geneva, Switzerland.
-
-
-
-
17
-
-
0029862923
-
Clinical significance of reported changes in pain severity
-
Todd K., Funk K., Funk J., and Bonacci R. Clinical significance of reported changes in pain severity. Ann Emerg Med 27 4 (1996) 485-489
-
(1996)
Ann Emerg Med
, vol.27
, Issue.4
, pp. 485-489
-
-
Todd, K.1
Funk, K.2
Funk, J.3
Bonacci, R.4
-
18
-
-
4043121805
-
Unresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor
-
Hayashi T., Tanaka I., Shima M., and et a. Unresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor. Haemophilia 10 4 (2004) 397-400
-
(2004)
Haemophilia
, vol.10
, Issue.4
, pp. 397-400
-
-
Hayashi, T.1
Tanaka, I.2
Shima, M.3
et, a.4
-
19
-
-
0033373301
-
Prevalence and outcome of intracranial haemorrhage in haemophiliacs - a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH)
-
Klinge J., Auberger K., Auerswald G., Brackmann H., Mauz-Korholz C., and Kreuz W. Prevalence and outcome of intracranial haemorrhage in haemophiliacs - a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH). Eur J Pediatr 158 suppl 3 (1999) S162-S165
-
(1999)
Eur J Pediatr
, vol.158
, Issue.SUPPL. 3
-
-
Klinge, J.1
Auberger, K.2
Auerswald, G.3
Brackmann, H.4
Mauz-Korholz, C.5
Kreuz, W.6
-
20
-
-
24644434299
-
Intracranialhaemorrhages in French haemophilia patients (1991-2001): clinical presentation, management and prognosis factors for death
-
Stieltjes N., Calvez T., Demiguel V., et al. Intracranialhaemorrhages in French haemophilia patients (1991-2001): clinical presentation, management and prognosis factors for death. Haemophilia 11 5 (2005) 452-458
-
(2005)
Haemophilia
, vol.11
, Issue.5
, pp. 452-458
-
-
Stieltjes, N.1
Calvez, T.2
Demiguel, V.3
-
21
-
-
6544275284
-
Prevalence and incidence of intracranial haemorrhage in a population of children with haemophilia
-
Nelson Jr. M., Maeder M., Usner D., et al., Hemophilia Growth and Development Study. Prevalence and incidence of intracranial haemorrhage in a population of children with haemophilia. Haemophilia 5 5 (1999) 306-312
-
(1999)
Haemophilia
, vol.5
, Issue.5
, pp. 306-312
-
-
Nelson Jr., M.1
Maeder, M.2
Usner, D.3
-
22
-
-
33645995723
-
Unresolved issues in diagnosis and management of inherited bleeding disorders in the perinatal period: a White Paper of the Perinatal Task Force of the Medical and Scientific Advisory Council of the National Hemophilia Foundation, USA
-
Kulkarni R., Ponder K., James A., and et a. Unresolved issues in diagnosis and management of inherited bleeding disorders in the perinatal period: a White Paper of the Perinatal Task Force of the Medical and Scientific Advisory Council of the National Hemophilia Foundation, USA. Haemophilia 12 3 (2006) 205-211
-
(2006)
Haemophilia
, vol.12
, Issue.3
, pp. 205-211
-
-
Kulkarni, R.1
Ponder, K.2
James, A.3
et, a.4
-
23
-
-
0034902098
-
Changes in the occurrence of and risk factors for hemophilia-associated intracranial hemorrhage
-
Nuss R., Soucie J., and Evatt B. Changes in the occurrence of and risk factors for hemophilia-associated intracranial hemorrhage. Am J Hematol 68 1 (2001) 37-42
-
(2001)
Am J Hematol
, vol.68
, Issue.1
, pp. 37-42
-
-
Nuss, R.1
Soucie, J.2
Evatt, B.3
-
24
-
-
24644485701
-
Iliopsoas haemorrhage in patients with haemophilia: results from one centre
-
Balkan C., Kavakli K., and Karapinar D. Iliopsoas haemorrhage in patients with haemophilia: results from one centre. Haemophilia 11 5 (2005) 463-467
-
(2005)
Haemophilia
, vol.11
, Issue.5
, pp. 463-467
-
-
Balkan, C.1
Kavakli, K.2
Karapinar, D.3
-
25
-
-
84949451048
-
Pathogenesis of musculoskeletal complications of haemophilia
-
Rodriguez-Merchan E., and Lee C. (Eds), Blackwell Science, Ltd., Oxford, England
-
Rodriguez-Merchan E. Pathogenesis of musculoskeletal complications of haemophilia. In: Rodriguez-Merchan E., and Lee C. (Eds). Inhibitors in Patients With Hemophilia (2002), Blackwell Science, Ltd., Oxford, England 115-119
-
(2002)
Inhibitors in Patients With Hemophilia
, pp. 115-119
-
-
Rodriguez-Merchan, E.1
-
26
-
-
33747203480
-
Surgical excision of a giant pelvic pseudotumour in a patient with haemophilia A
-
Valentino L., Martinowitz U., Doolas A., and Murali P. Surgical excision of a giant pelvic pseudotumour in a patient with haemophilia A. Haemophilia 12 5 (2006) 541-544
-
(2006)
Haemophilia
, vol.12
, Issue.5
, pp. 541-544
-
-
Valentino, L.1
Martinowitz, U.2
Doolas, A.3
Murali, P.4
-
27
-
-
0013297123
-
-
Baxter Healthcare Corporation, Westlake Village, CA
-
FEIBA V. [package insert] (April 2005), Baxter Healthcare Corporation, Westlake Village, CA
-
(2005)
[package insert]
-
-
FEIBA, V.1
-
29
-
-
43449099042
-
-
NovoSeven. European Medicines Agency (EMEA). EPARs for authorised medicinal products for human use. Annex I - Summary of product characteristics. http://www.emea.europa.eu/humandocs/Humans/EPAR/novoseven/novoseven.htm. Updated March 9, 2007. Accessed October 8, 2007.
-
NovoSeven. European Medicines Agency (EMEA). EPARs for authorised medicinal products for human use. Annex I - Summary of product characteristics. http://www.emea.europa.eu/humandocs/Humans/EPAR/novoseven/novoseven.htm. Updated March 9, 2007. Accessed October 8, 2007.
-
-
-
-
30
-
-
4043155658
-
Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors
-
Schneiderman J., Nugent D., and Young G. Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors. Haemophilia 10 4 (2004) 347-351
-
(2004)
Haemophilia
, vol.10
, Issue.4
, pp. 347-351
-
-
Schneiderman, J.1
Nugent, D.2
Young, G.3
-
31
-
-
34248551364
-
Sequential therapy with activated prothrombin complex concentrates and recombinant FVIIa in patients with severe haemophilia and inhibitors: update of our previous experience
-
Schneiderman J., Rubin E., Nugent D., and Young G. Sequential therapy with activated prothrombin complex concentrates and recombinant FVIIa in patients with severe haemophilia and inhibitors: update of our previous experience. Haemophilia 13 3 (2007) 244-248
-
(2007)
Haemophilia
, vol.13
, Issue.3
, pp. 244-248
-
-
Schneiderman, J.1
Rubin, E.2
Nugent, D.3
Young, G.4
-
32
-
-
13244262642
-
Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity
-
Aledort L. Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity. JThrombHaemost 2 10 (2004) 1700-1708
-
(2004)
JThrombHaemost
, vol.2
, Issue.10
, pp. 1700-1708
-
-
Aledort, L.1
-
33
-
-
0348218225
-
Immunoadsorption for coagulation factor inhibitors: a retrospective critical appraisal of 10 consecutive cases from a single institution
-
Rivard G., St Louis J., Lacroix S., Champagne M., and Rock G. Immunoadsorption for coagulation factor inhibitors: a retrospective critical appraisal of 10 consecutive cases from a single institution. Haemophilia 9 6 (2003) 711-716
-
(2003)
Haemophilia
, vol.9
, Issue.6
, pp. 711-716
-
-
Rivard, G.1
St Louis, J.2
Lacroix, S.3
Champagne, M.4
Rock, G.5
-
34
-
-
0019753424
-
Current status and trends in the treatment of hemophilic patients with inhibitors
-
Bloom A. Current status and trends in the treatment of hemophilic patients with inhibitors. Prog Clin Biol Res 72 (1981) 123-138
-
(1981)
Prog Clin Biol Res
, vol.72
, pp. 123-138
-
-
Bloom, A.1
-
35
-
-
0141921424
-
Intracranial haemorrhage among a population of haemophilic patients in Brazil
-
Antunes S., Vicari P., Cavalheiro S., and Bordin J. Intracranial haemorrhage among a population of haemophilic patients in Brazil. Haemophilia 9 5 (2003) 573-577
-
(2003)
Haemophilia
, vol.9
, Issue.5
, pp. 573-577
-
-
Antunes, S.1
Vicari, P.2
Cavalheiro, S.3
Bordin, J.4
-
36
-
-
33646002352
-
Considerations in the evaluation of haemophilia patients for short-term prophylactic therapy: a paediatric and adult case study
-
Luchtman-Jones L., Valentino L., and Manno C. Considerations in the evaluation of haemophilia patients for short-term prophylactic therapy: a paediatric and adult case study. Haemophilia 12 1 (2006) 82-86
-
(2006)
Haemophilia
, vol.12
, Issue.1
, pp. 82-86
-
-
Luchtman-Jones, L.1
Valentino, L.2
Manno, C.3
-
37
-
-
10744231994
-
Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay
-
Turecek P., Varadi K., Keil B., and et a. Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay. Pathophysiol Haemost Thromb 33 1 (2003) 16-22
-
(2003)
Pathophysiol Haemost Thromb
, vol.33
, Issue.1
, pp. 16-22
-
-
Turecek, P.1
Varadi, K.2
Keil, B.3
et, a.4
-
38
-
-
37749011450
-
-
Baxter Healthcare Corp, Westlake Village, Calif
-
Varadi K., Schoppmann A., and Turecek P. Mode of Action of FEIBA: Applying a Cell Based Model of Hemostasis. Baxter Scientific Series Vol No. 5 (2006), Baxter Healthcare Corp, Westlake Village, Calif
-
(2006)
Mode of Action of FEIBA: Applying a Cell Based Model of Hemostasis. Baxter Scientific Series Vol No. 5
-
-
Varadi, K.1
Schoppmann, A.2
Turecek, P.3
-
39
-
-
0031760564
-
Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII
-
Hoffman M., Monroe III D., and Roberts H. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinolysis 9 suppl 1 (1998) S61-S65
-
(1998)
Blood Coagul Fibrinolysis
, vol.9
, Issue.SUPPL. 1
-
-
Hoffman, M.1
Monroe III, D.2
Roberts, H.3
-
40
-
-
0017785868
-
Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder [letter]
-
Brackmann H., and Gormsen J. Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder [letter]. Lancet 2 8044 (1977) 933
-
(1977)
Lancet
, vol.2
, Issue.8044
, pp. 933
-
-
Brackmann, H.1
Gormsen, J.2
-
41
-
-
33750342991
-
A retrospective postlicensure survey of FEIBA efficacy and safety
-
DiMichele D., and Negrier C. A retrospective postlicensure survey of FEIBA efficacy and safety. Haemophilia 12 4 (2006) 352-362
-
(2006)
Haemophilia
, vol.12
, Issue.4
, pp. 352-362
-
-
DiMichele, D.1
Negrier, C.2
-
42
-
-
0038441421
-
Long-term FEIBA prophylaxis does not prevent progression of existing joint disease
-
Hilgartner M., Makipernaa A., and DiMichele D. Long-term FEIBA prophylaxis does not prevent progression of existing joint disease. Haemophilia 9 3 (2003) 261-268
-
(2003)
Haemophilia
, vol.9
, Issue.3
, pp. 261-268
-
-
Hilgartner, M.1
Makipernaa, A.2
DiMichele, D.3
-
43
-
-
34248562674
-
Prophylactic treatment with activated prothrombin complex concentrate (FEIBA) reduces the frequency of bleeding episodes in paediatric patients with haemophilia A and inhibitors
-
Leissinger C., Becton D., Ewing N., and Valentino L. Prophylactic treatment with activated prothrombin complex concentrate (FEIBA) reduces the frequency of bleeding episodes in paediatric patients with haemophilia A and inhibitors. Haemophilia 13 3 (2007) 249-255
-
(2007)
Haemophilia
, vol.13
, Issue.3
, pp. 249-255
-
-
Leissinger, C.1
Becton, D.2
Ewing, N.3
Valentino, L.4
-
44
-
-
0028232368
-
Pharmacokinetics and pharmacodynamics of recombinant factor VIIa
-
Lindley C., Sawyer W., Macik B., and et a. Pharmacokinetics and pharmacodynamics of recombinant factor VIIa. Clin Pharmacol Ther 55 6 (1994) 638-648
-
(1994)
Clin Pharmacol Ther
, vol.55
, Issue.6
, pp. 638-648
-
-
Lindley, C.1
Sawyer, W.2
Macik, B.3
et, a.4
-
45
-
-
4043184093
-
Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia A
-
Villar A., Aronis S., Morfini M., and et a. Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia A. Haemophilia 10 4 (2004) 352-359
-
(2004)
Haemophilia
, vol.10
, Issue.4
, pp. 352-359
-
-
Villar, A.1
Aronis, S.2
Morfini, M.3
et, a.4
-
46
-
-
3242737794
-
Monitoring the bioavailability of FEIBA with a thrombin generation assay
-
Varadi K., Negrier C., Berntorp E., and et a. Monitoring the bioavailability of FEIBA with a thrombin generation assay. JThrombHaemost 1 11 (2003) 2374-2380
-
(2003)
JThrombHaemost
, vol.1
, Issue.11
, pp. 2374-2380
-
-
Varadi, K.1
Negrier, C.2
Berntorp, E.3
et, a.4
-
47
-
-
34548096392
-
Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors
-
Konkle B., Ebbesen L., Erhardtsen E., and et a. Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors. JThrombHaemost 5 9 (2007) 1904-1913
-
(2007)
JThrombHaemost
, vol.5
, Issue.9
, pp. 1904-1913
-
-
Konkle, B.1
Ebbesen, L.2
Erhardtsen, E.3
et, a.4
-
48
-
-
34548301664
-
Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres
-
Morfini M., Auerswald G., Kobelt R., and et a. Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres. Haemophilia 13 5 (2007) 502-507
-
(2007)
Haemophilia
, vol.13
, Issue.5
, pp. 502-507
-
-
Morfini, M.1
Auerswald, G.2
Kobelt, R.3
et, a.4
-
49
-
-
30444433618
-
Therapeutic decision-making in inhibitor patients
-
Allen G., and Aledort L. Therapeutic decision-making in inhibitor patients. Am J Hematol 81 1 (2006) 71-72
-
(2006)
Am J Hematol
, vol.81
, Issue.1
, pp. 71-72
-
-
Allen, G.1
Aledort, L.2
-
50
-
-
0036304070
-
Possible synergy between recombinant factor VIIa and prothrombin complex concentrate in hemophilia therapy
-
Key N., Christie B., Henderson N., and Nelsestuen G. Possible synergy between recombinant factor VIIa and prothrombin complex concentrate in hemophilia therapy. Thromb Haemost 88 1 (2002) 60-65
-
(2002)
Thromb Haemost
, vol.88
, Issue.1
, pp. 60-65
-
-
Key, N.1
Christie, B.2
Henderson, N.3
Nelsestuen, G.4
-
51
-
-
43449115273
-
-
PRO-FEIBA. A prospective, randomized, cross-over study of an activated prothrombin complex concentrate for secondary prophylaxis in patients with hemophilia A and inhibitors. ClinicalTrials.gov Web site. http://www.clinicaltrial.gov/ct/show/NCT00221195?order=6. Verified September 2005. Accessed August 2, 2006.
-
PRO-FEIBA. A prospective, randomized, cross-over study of an activated prothrombin complex concentrate for secondary prophylaxis in patients with hemophilia A and inhibitors. ClinicalTrials.gov Web site. http://www.clinicaltrial.gov/ct/show/NCT00221195?order=6. Verified September 2005. Accessed August 2, 2006.
-
-
-
|